Key Takeaways NVO surged after Parvus Asset Management raised its stake to influence the CEO succession process. NVO will present positive data from STEP UP, REDEFINE 1 and 2, and amycretin trials shortly. Novo Nordisk faces extreme pressure from LLY in obesity care.Shares of Novo Nordisk (NVO) gained 5% on June 10, following a report that activist hedge fund Parvus Asset Management is building a stake in the company.Per the Financial Times, this London-based hedge fund, Parvus Asset Management, is raisin ...